The new research project now aims to provide a holistic view of the significance of plastic particles during pregnancy. To ...

Two suspected cases of Guillain-Barré Syndrome (GBS) have been found in the Delhi National Capital Region (NCR), according to ...

Panelists discuss how the data from the BRAVE-AA1 and BRAVE-AA2 phase 3 trials demonstrated the safety and efficacy of baricitinib, leading to its FDA approval in 2022 as the first systemic treatment ...

The patient has iMCD, which has a poor survival rate and few treatment options but an AI tool searched through 4,000 ...

Chronic lymphocytic leukemia (CLL) is a B-cell malignancy, with disease progression ranging from slow and indolent to ...

The FDA has granted Fast Track Designation to Adicet Bio’s ADI-001, an allogeneic gamma delta CAR T-cell therapy, for ...

MANILA, Philippines — Being diagnosed with a life-long condition like Type 1 Diabetes can cause fear for the kid and his ...

CHICAGO, IL / ACCESS Newswire / February 5, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company")(NASDAQ:COSM) , a ...

Maharashtra reports a significant increase in Guillain-Barre Syndrome cases, with 170 suspected and 132 confirmed. State ...

Set to enter hospice care, a patient with idiopathic multicentric Castleman's disease is now in remission after treatment with a medication identified by an AI-guided analysis.

Elsewhere today at the Medlab Middle East Congress, the Clinical Chemistry track explored the role of artificial intelligence ...

Vaccines do not cause autism. You’ve almost certainly read that before — but often without a full explanation of how we know ...